Treatment of Alopecia Areata of the Scalp With Intradermal Injections of Botulinum Toxin

• Status: Completed
• Trial end date: 2009-10-30
• Target enrollment: 0
• Participant gender: All

Summary

The purpose of this study is to examine prospectively the safety and efficacy of Botulinum Toxin A (Botox) injections in the treatment of patients with alopecia areata of the scalp.

• Phase: N/A
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: University of British Columbia
• Treatments: abobotulinumtoxinA; Botulinum Toxins; Botulinum Toxins, Type A; incobotulinumtoxinA; onabotulinumtoxinA

Criteria

Inclusion Criteria:

• Patients with long standing alopecia areata, patches must be at least 4 cm in diameter

Exclusion Criteria:

• Intake of drugs that interfere with Botulinum toxin A such as gentamicin, tobramycin, clindamycin and lincomycin; medications used to treat heart rhythm problems, such as quinidine; and medications used to treat other conditions, such as myasthenia gravis, ALS or Alzheimer's disease.

• Neuromuscular disorders such as Myasthenia gravis and Lambert-Eaton-Syndrome.

• Treatment with another investigational drug within 4 weeks prior to anticipated first treatment.

• Females who are pregnant, planning to become pregnant during the study period, or breastfeeding.